These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 39558)

  • 21. Reaction of microsomal and cytosolic enzymes with N-arylacetohydroxamic acids in the presence of oxygen.
    Lenk W; Scharmer U
    Adv Exp Med Biol; 1981; 136 Pt B():951-68. PubMed ID: 7344521
    [No Abstract]   [Full Text] [Related]  

  • 22. Ca2+-activated, fatty acid-dependent guanylate cyclase in synaptic plasma membranes and its requirement for Ca2+ and Mg-GTP in the activation.
    Asakawa T; Takano M; Enomoto K; Hayama K
    Adv Exp Med Biol; 1984; 175():173-86. PubMed ID: 6149673
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulfuric acid esters as ultimate electrophilic and carcinogenic metabolites of some alkenylbenzenes and aromatic amines in mouse liver.
    Miller EC; Miller JA; Boberg EW; Delclos KB; Lai CC; Fennell TR; Wiseman RW; Liem A
    Carcinog Compr Surv; 1985; 10():93-107. PubMed ID: 3904999
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for a second arylhydroxamic acid acyltransferase species in the small intestine of the rat.
    Olive CW; King CM
    Chem Biol Interact; 1975 Dec; 11(6):599-604. PubMed ID: 1201619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of N-hydroxy-2-acetylaminofluorene-DNA adducts in rat liver measured by radioimmunoassay.
    Rio P; Bazgar S; Leng M
    Carcinogenesis; 1982; 3(2):225-7. PubMed ID: 6978201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes.
    Smith TJ; Hanna PE
    Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of carcinogenic amino derivatives in various species and DNA alkylation by their metabolites.
    Schut HA; Castonguay A
    Drug Metab Rev; 1984; 15(4):753-839. PubMed ID: 6437779
    [No Abstract]   [Full Text] [Related]  

  • 28. Free-radical events in chemical and biochemical reactions involving carcinogenic arylamines.
    Floyd RA
    Radiat Res; 1981 May; 86(2):243-63. PubMed ID: 6262857
    [No Abstract]   [Full Text] [Related]  

  • 29. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
    Kaneda S; Seno T; Takeishi K
    J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
    McGregor D
    Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol.
    Meerman JH; Beland FA; Mulder GJ
    Carcinogenesis; 1981; 2(5):413-6. PubMed ID: 7273322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The initiation of gamma-glutamyltranspeptidase positive foci in the rat liver by N-hydroxy-2-acetylaminofluorene. The effect of the sulfation inhibitor pentachlorophenol.
    Meerman JH
    Carcinogenesis; 1985 Jun; 6(6):893-7. PubMed ID: 2860981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of guanylate cyclase activity by several fatty acids.
    Asakawa T; Scheinbaum I; Ho R
    Biochem Biophys Res Commun; 1976 Nov; 73(1):141-8. PubMed ID: 11796
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of glutathione depletion on the hepatotoxicity and covalent binding rat liver macromolecules of N-hydroxy-2-acetylaminofluorene.
    Meerman JH; Tijdens RB
    Cancer Res; 1985 Mar; 45(3):1132-9. PubMed ID: 2578873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and binding of benzo(a)pyrene and 2-acetylaminofluorene by short-term organ cultures of human and rat bladder.
    Moore BP; Hicks RM; Knowles MA; Redgrave S
    Cancer Res; 1982 Feb; 42(2):642-8. PubMed ID: 6275985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-hydroxy-2-acetylaminofluorene as effective inhibitor of aldehyde oxidase.
    Tatsumi K; Kitamura S
    Biochem Biophys Res Commun; 1986 Jul; 138(1):312-7. PubMed ID: 3741414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of guanylate cyclase in synaptic plasma membranes of cerebral cortex by free fatty acids.
    Asakawa T; Takenoshita M; Uchida S; Tanaka S
    J Neurochem; 1978 Jan; 30(1):162-6. PubMed ID: 23416
    [No Abstract]   [Full Text] [Related]  

  • 40. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.